#425 Don’t Lose Sleep Over When to Take Blood Pressure Medications
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
- 5 systematic reviews of randomized controlled trials (RCTs) in the past 2 years compared cardiovascular events when taking ≥1 antihypertensive drugs at bedtime/evening versus taking them all in the morning.1–5
- Focusing on systematic reviews comparing timing only (excluding RCTs with different drugs in the intervention and comparator groups):1–3
- 5 RCTs with 46,606 patients (mean age 63 years, 45% women).
- Over a median 5.2 years of follow-up, no statistically significant difference in cardiovascular events1,2 or deaths.1–3
- Inconsistent results between trials driven by 2 RCTs by the same group (Hygia and MAPEC) at risk of bias.1,6
- Focusing on 3 RCTs at low risk of bias (Canadian BedMed7 and BedMed-Frail8, and the UK TIME9):
- No difference in cardiovascular events, death, cognition, fractures, or glaucoma.1
- More patients randomized to morning administration took their medications at the allocated time.7,9
- Rationale for bedtime dosing based on observational studies suggesting that nighttime blood pressure better predicts cardiovascular events than daytime or in-office measurement, and that absence of the natural decline in blood pressure during sleep (“non-dipping”) is associated with increased cardiovascular risk.6,10
- Taking antihypertensive drugs in the evening lowered 24-hour ambulatory blood pressure by ~1-2 mmHg compared with morning administration, but not statistically different after excluding trials by the Hygia/MAPEC investigators.11
- A previous Tools for Practice based on the MAPEC trial suggested taking antihypertensive drugs at night might reduce cardiovascular events, but cautioned about several important trial limitations.10
- Guidelines emphasize the importance of antihypertensive drug adherence and recommend they be taken at the most convenient time of day for an individual patient, noting the evidence showing administration time does not alter cardiovascular risk reduction.12







